Professional
Added to YB: 2024-11-26
Pitch date: 2024-11-24
BAYN.DE [neutral]
Bayer Aktiengesellschaft
+99.93%
current return
Author Info
The Superinvestors of Augustusville runs a small family office and shares pitches for their investments. Sign up for their newsletter.
Company Info
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
Market Cap
EUR 36.9B
Pitch Price
EUR 19.85
Price Target
N/A
Dividend
0.29%
EV/EBITDA
7.31
P/E
-10.20
EV/Sales
1.47
Sector
Pharmaceuticals
Category
turnaround
Bottom Fishing in Sick Man's Land - Bayer Aktiengesellschaft
BAYN.DE: German pharma giant post-Monsanto acquisition struggles with debt, litigation, cyclicality. New CEO Anderson leading turnaround: efficiency programs, employee cuts, dividend slash. Generating cash, BBB rating. 6x EBITDA valuation attractive. History of comebacks and spin-offs (Lanxess, Covestro) offers hope.
Read full article (2 min)